14
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Amodiaquine treatment of uncomplicated malaria in children, in an area of chloroquine-resistant Plasmodium falciparum in north-central Nigeria

, , , , , , , , & show all
Pages 663-669 | Published online: 18 Jul 2013

References

  • Anon. (1989). Guidelines for Malaria Control in Nigeria. Lagos: Gabumo Press.
  • Anon. (1990). Guidelines for Malaria Control for Physicians in Nigeria. Lagos: Gabumo Press.
  • Asindi, A. A., Ekanem, E. E., Ibia, E. O. & Nwangwa, M. A. (1993). Upsurge of malaria-related convulsions in a paediatric emergency room in Nigeria. Consequence of emerging resistant Plasmodium falciparum. Tropical and Geographical Medicine, 45, 110–113.
  • Bloland, P. B., Lakritz, E. M., Kazembe, P. M., Were, J. B. D., Steketee, R. & Campbell, C. G. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 932–937.
  • Brewster, D. R. & Greenwood, B. M. (1993). Seasonal variation of paediatric diseases in the Gambia, West Africa. Annals of Tropical Paediatrics, 13, 133–146.
  • Bruce-Chwatt, L. J., Black, R. H., Canfield, C. J., Clyde, D. F., Peters, W. & Wernsdorfer, W. H. (Eds) (1986). Chemotherapy of Malaria, 2nd Edn. Geneva: World Health Organization.
  • Fleming, A. F. & Werblifiska, B. (1982). Anaemia in childhood in the guinea savanna of Nigeria. Annals of Tropical Paediatrics, 2,161–173.
  • Hatton, C., Peto, T., Bunch, C., Pasvol, G., Russel, S., Singer C., Edwards, G. & Winstanley, P. (1986). Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet, i, 411–413.
  • Krishna, S. & White, N. J. (1996). Pharmacokinetics of quinine, chloroquine and amodiaquine — clinical implications. Clinical Pharmacokinetics, 30, 263–299.
  • Lelijveld, J. & Kortmann, H. (1970). The eosin colour test of Dill Glazko: a simple test to detect chloroquine in urine. Bulletin of the World Health Organization, 42, 477–479.
  • Neftel, K., Woodtly, W., Schmidt, R., Frich, P. & Fehr, J. (1986). Amodiaquine to induce agranulo-cytosis and liver damage. British Medical Journal, 292, 721–723.
  • Olliaro, P., Nevill, C., LeBras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196–1201.
  • Sowunmi, A. (2002). A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine—sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology, 96, 227–238.
  • Trape, J. F. (1999). Impact of drug resistance on morbidity and mortality in malaria infections in Africa. Proceedings of the MIM African Malaria Conference, Durban, South Africa, pp. 36-42 (http://mim.nih.gov/ english/achievements/conference.html#durban report).
  • White, N. J. (1999). Delaying antimalarial drug resist-ance with combination chemotherapy. Parassitologia, 41, 301–308.
  • World Health Organization (1995). Guidelines for Good Clinical Practice for Trials on Pharmaceutical Products. Technical Report Series No. 850. Geneva: WHO. World Health Organization (1996). Assessment of Thera-peutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Document WHO/MAL/96. 1077. Geneva: WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.